Compare Bio Protocol (BIO) vs iExec RLC (RLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs iExec RLC — how do they compare? Bio Protocol trades at Rp512.09 (market cap Rp1,15T, Rp263,61M 24h volume), while iExec RLC trades at Rp5,216 (market cap Rp453,85M, Rp22,38M 24h volume). The key difference: Bio Protocol is far larger — about 2533.9× iExec RLC's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 87M / 87M RLC (100%) for iExec RLC. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and iExec RLC for 34 Days on average.
| BIO | RLC | |
|---|---|---|
Market Cap | Rp1,15T | Rp453,85M |
Volume (24h) | Rp263,61M | Rp22,38M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 87M / 87M RLC (100%) |
Typical Hold Time | 16 Days | 34 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
iExec RLC is trading at Rp5,219 with a market cap of Rp452.09M, showing bearish technical signals from moving averages while oscillators remain neutral. The token is fully circulated with a 34-day average hold time, indicating moderate holding behavior. No major protocol updates or ecosystem news have been reported recently, keeping fundamental developments quiet.
Overall outlook is cautious due to bearish technical pressure and lack of positive catalysts. Key opportunities lie in potential rebounds from support levels, while risks include low liquidity and broader crypto market volatility. Investors should monitor trading volume and on-chain activity for signs of renewed interest.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About iExec RLC
iExec (RLC) is the leading provider of blockchain-based decentralized computing. Blockchain is utilized to organize a market network where people can monetize their computing power as well as applications and even datasets. iExec can support applications in fields such as big data, healthcare, AI, rendering and fintech. IExec was founded on Oct. 16, 2016, with the goal to reinvent cloud computing through the creation of a new cloud computing paradigm.
Read more on RLC →
